These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Letter: Tryptophan in depression. Peet M Lancet; 1974 Oct; 2(7887):1012. PubMed ID: 4138421 [No Abstract] [Full Text] [Related]
3. Letter: Tryptophan/imipramine in depression. Jensen K; Fruensgaard K; Ahlfors UG; Pihkanen TA; Tuomikoski S; Ose E; Dencker SJ; Lindberg D; Nagy A Lancet; 1975 Nov; 2(7941):920. PubMed ID: 53394 [No Abstract] [Full Text] [Related]
4. L-tryptophan in depression. Coppen A; Noguera R Lancet; 1970 May; 1(7656):1111. PubMed ID: 4191980 [No Abstract] [Full Text] [Related]
5. Letter: Tryptophan and depression. Rao B; Broadhurst AD Br Med J; 1976 Feb; 1(6007):460. PubMed ID: 766901 [No Abstract] [Full Text] [Related]
6. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Coppen A; Whybrow PC; Noguera R; Maggs R; Prange AJ Arch Gen Psychiatry; 1972 Mar; 26(3):234-41. PubMed ID: 4551048 [No Abstract] [Full Text] [Related]
7. Monoamine precursors in the treatment of depression. Carroll BJ Clin Pharmacol Ther; 1971; 12(5):743-61. PubMed ID: 4936139 [No Abstract] [Full Text] [Related]
8. Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study. Chouinard G; Young SN; Annable L; Sourkes TL Acta Psychiatr Scand; 1979 Apr; 59(4):395-414. PubMed ID: 155389 [TBL] [Abstract][Full Text] [Related]
10. Psychopharmacology. Yesterday, today and tomorrow: a point of view. Stancer HC Can Psychiatr Assoc J; 1973 Oct; 18(5):371-6. PubMed ID: 4583435 [No Abstract] [Full Text] [Related]
11. Comparable therapeutic efficacy of tryptophan and imipramine: average therapeutic ratings versus "true" equivalence. An important difference. Kline NS; Shah BK Curr Ther Res Clin Exp; 1973 Jul; 15(7):484-7. PubMed ID: 4198311 [No Abstract] [Full Text] [Related]
12. Potentiation of a monoamine oxidase inhibitor by tryptophan. Glassman AH; Platman SR J Psychiatr Res; 1969 Dec; 7(2):83-8. PubMed ID: 4917709 [No Abstract] [Full Text] [Related]
13. Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes. Coppen A Psychiatr Neurol Neurochir; 1969; 72(2):173-80. PubMed ID: 5792057 [No Abstract] [Full Text] [Related]
14. Reduced central serotonergic activity in mania: implications for the relationship between depression and mania. Mendels J; Frazer A Br J Psychiatry; 1975 Mar; 126():241-8. PubMed ID: 1125505 [No Abstract] [Full Text] [Related]
15. Comparative trial of a new mono-amine oxidase inhibitor in depression. Wheatley D Br J Psychiatry; 1970 Nov; 117(540):573-4. PubMed ID: 4921178 [No Abstract] [Full Text] [Related]
17. Tryptophan in the treatment of depression. Young SN; Chouinard G; Annable L Adv Exp Med Biol; 1981; 133():727-37. PubMed ID: 6459010 [No Abstract] [Full Text] [Related]
18. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lapin IP; Oxenkrug GF Lancet; 1969 Jan; 1(7586):132-6. PubMed ID: 4178247 [No Abstract] [Full Text] [Related]
19. Drugs for depression. S Afr Med J; 1966 Feb; 40(9):181-2. PubMed ID: 5909384 [No Abstract] [Full Text] [Related]
20. Tryptophan dosage critical for its antidepressant effect. Chouinard G; Young SN; Annable L; Sourkes TL Br Med J; 1978 May; 1(6124):1422. PubMed ID: 148309 [No Abstract] [Full Text] [Related] [Next] [New Search]